Brief: Pure Biologics Gets Positive Decision From PARP Regarding Financing Of Co's Product Brands On Foreign Markets
16/08/2019 15:20
Aug 16 (Reuters) - Pure Biologics SA PUR1.WA :
* SAYS GETS POSITIVE DECISION FROM PARP (POLISH AGENCY FOR
ENTERPRISE DEVELOPMENT) REGARDING FINANCING OF CO'S PRODUCT
BRANDS ON FOREIGN MARKETS
* SAYS TOTAL PROJECT VALUE IS 242,000 ZLOTYS, WHEREAS
SUBSIDY FROM
EUROPEAN UNION FUNDS IS 182,100 ZLOTYS
Source text for Eikon: ID:nEM6cmKtqa
Further company coverage: PUR1.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects